Navigation Links
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Date:10/1/2013

011) were used in this analysis.

The list of accepted abstracts for The Liver Meeting can be accessed on www.aasld.org.

ABT-450 was discovered during the course of the ongoing collaboration between AbbVie and Enanta Pharmaceuticals for HCV protease inhibitors and regimens that include protease inhibitors. ABT-450 is being developed by AbbVie for use in combination with AbbVie's other investigational medicines for the treatment of HCV.

About the Hepatitis C Virus
Across the world, about 160 million people are chronically infected with hepatitis C.[1] Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus (HCV).[2] HCV is transmitted when an infected person's blood enters the bloodstream of another person.[3]

For the hepatitis C virus, there are six major HCV genotypes (GT1-6).[4] Presently, there is no vaccine for the hepatitis C virus (HCV) infection.3 Decision to treat is dependent on a number of factors such as the amount of liver damage present, other conditions the patient may have, amount of virus in the body, and viral genotype.4 If treatment is needed, a hepatitis C infection is typically treated with a combination of antivirals.3

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie<
'/>"/>

SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
2. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
3. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
4. AbbVie Declares Quarterly Dividend
5. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
7. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
8. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
9. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
11. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Among 1,000 U.S. consumers, the majority (65.3 percent) ... surveyed are aware of prescription savings cards, and just ... to findings from a new survey released today by ... improving the health and well-being of individuals, families and ... and women, ages 21 and older, on their spending, ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
(Date:8/3/2015)...  Landauer, Inc. (NYSE: LDR ), a recognized ... outsourced medical physics services and high quality medical consumable ... the fiscal third quarter 2015 after the market close ... Company will also host a conference call for investors ... Time (10:00 a.m. Eastern Time). Investors may access the ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2
... Schering-Plough,Corporation (NYSE: SGP ) and The ... of Baltimore today announced results of the ... Eptifibatide to,Arrest the Reactivity of Platelets) study, ... IIIa inhibitor, significantly inhibited,platelet aggregation when added ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today ... a,scientific consortium led by the University of North ... The Bill & Melinda Gates Foundation,(the "Gates Foundation"), ... and leishmania. This grant is part of the ...
Cached Medicine Technology:Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 2Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 3Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 4Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 5Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
(Date:8/4/2015)... , ... August 04, 2015 , ... ... manufacturing, label design, product packaging, and fulfillment services, joined over 200 other Long ... event was held on Tuesday, July 28th at Jones Beach State Park in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... complete with full examination now offered by the world renowned Beverly Hills ... aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve an outer ...
(Date:8/4/2015)... ... August 04, 2015 , ... Montclair State University and Atlantic Health System ... its kind in New Jersey, which starting this Fall will help prepare those entering ... partnered with Atlantic Health System, one of the largest health care organizations in New ...
(Date:8/4/2015)... Denver, CO (PRWEB) , ... August 04, 2015 ... ... for skilled nursing homes and other long-term care facilities, today announced details of ... (QAPI) for nursing homes and centers. , Providigm’s QAPI Accreditation program , ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sin City Gallery is delighted ... a diverse group of exceptionally talented female artists. The exhibition premieres at ... September 25-27, 2015 in Downtown Las Vegas. Curated by gallery director Dr. Laura ...
Breaking Medicine News(10 mins):Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... March 12 Jordan Lapides, a 54-year-old teacher of Spirituality ... And Spiritual Development in Pennsylvania, was recently challenged by one ... his weight problem. Lapides took up the challenge and ... has sparked a media frenzy. He has appeared on television, ...
... the counter treatment for,chronic and acute wounds. The revolutionary new product ... prevents scar formation. , ... Bellwood, IL (PRWEB) March ... on revolutionary technology in the healing of wounds. Based on a ...
... deployed as the electronic data capture and clinical data management system ... , ... New Haven, CT (PRWEB) March 12, 2009 ... the OpenClinica clinical data capture and management software for the Parkinson,s ...
... Colon(R) Educational Exhibit to Detroit Science Center, March 13 ... March 11 Colorectal cancer (cancer that begins either ... common cancer in both men and women in the ... 148,810 Americans were diagnosed with colorectal cancer in 2008, ...
... begin with one altruistic living donor, study explains, , , ... healthy young man stepped forward, willing to give one ... later, 10 people had received new kidneys from that ... started the first nonsimultaneous, extended altruistic-donor (NEAD) chain. The ...
... Salmonella bacteria research from two recent NASA ... bacteria,s disease-causing potential that hold promise for ... Earth.(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO )Salmonella is ... related illnesses. According to the Centers for ...
Cached Medicine News:Health News:54-Year-Old Psychology Teacher Loses 155 Pounds In 10 Months By Applying His Own Teachings To Himself 2Health News:Wound Be Gone: Quickly Gaining Strong Support from Clinician Experts in the Field of Wound Healing 2Health News:Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study 2Health News:Institute for Neurodegenerative Disorders Deploys OpenClinica EDC solution for Large Parkinson's Study 3Health News:Keep Your Rear in the Clear 2Health News:Keep Your Rear in the Clear 3Health News:Keep Your Rear in the Clear 4Health News:Living Kidney Donation Chains May Help More Get Transplants 2Health News:Living Kidney Donation Chains May Help More Get Transplants 3Health News:Space Research May Help Explain Salmonella Illness 2Health News:Space Research May Help Explain Salmonella Illness 3
... technology is the first and ... patented digital sensor all ... sensor. Dolphin ONE™ sensors both ... in the sensor, resulting in ...
Immersion Oil, 21,000 cs...
Immersion Oil, 1,250 cs...
... the standard - the ones to compare with, ... consistently led in the development and standardization of ... the record: , When the FDA set general ... Vitro Diagnostics in the 1970's, Cargille Immersion Oils ...
Medicine Products: